<DOC>
	<DOCNO>NCT02379650</DOCNO>
	<brief_summary>Recurrent pregnancy loss ( RPL ) affect 5 % couple try achieve parenthood . Most case RPL unexplained effective treatment improve likelihood pregnancy result live birth . This lead significant patient provider frustration emotional stress . Hydroxychloroquine ( HCQ ) medication commonly use pregnancy treat autoimmune connective tissue disease systemic lupus erythematosus ( SLE ) . This use show HCQ safe pregnancy . HCQ anti-inflammatory anti-thrombotic effect thus may improve pregnancy outcome couple unexplained RPL . Although provider already prescribe HCQ unexplained RPL , randomize control trial necessary determine true efficacy safety treatment . This study potential establish support new treatment option unexplained RPL .</brief_summary>
	<brief_title>Hydroxychloroquine ( HCQ ) Recurrent Pregnancy Loss</brief_title>
	<detailed_description />
	<mesh_term>Abortion , Spontaneous</mesh_term>
	<mesh_term>Fetal Death</mesh_term>
	<mesh_term>Hydroxychloroquine</mesh_term>
	<criteria>Women age 18 old Planning conception experience 2 unexplained pregnancy loss prior 20 week gestation one live birth Documented antiphospholipd antibody Uterine malformation parental chromosomal abnormality Known lupus medical condition require treatment hydroxychloroquine outside study protocol Any medical contraindication hydroxychloroquine aspirin therapy , include liver kidney disease , pregestational diabetes know retinopathy</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2016</verification_date>
</DOC>